Patents by Inventor Glen Gillis
Glen Gillis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9060963Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: GrantFiled: December 14, 2011Date of Patent: June 23, 2015Assignee: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Patent number: 8226956Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: GrantFiled: February 15, 2012Date of Patent: July 24, 2012Assignee: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Publication number: 20120142599Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: ApplicationFiled: February 15, 2012Publication date: June 7, 2012Applicant: ACTIVE ORGANICS, INC.Inventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Publication number: 20120121642Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: ApplicationFiled: December 14, 2011Publication date: May 17, 2012Applicant: ACTIVE ORGANICS, INC.Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Patent number: 8142792Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: GrantFiled: June 3, 2010Date of Patent: March 27, 2012Assignee: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Patent number: 8097258Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: GrantFiled: November 11, 2010Date of Patent: January 17, 2012Assignee: Active Organics, LPInventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Publication number: 20110129491Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: ApplicationFiled: November 11, 2010Publication date: June 2, 2011Applicant: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Patent number: 7854936Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: GrantFiled: January 14, 2008Date of Patent: December 21, 2010Assignee: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Publication number: 20100310598Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: ApplicationFiled: June 3, 2010Publication date: December 9, 2010Applicant: ACTIVE ORGANICS, LPInventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Patent number: 7776339Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: GrantFiled: January 11, 2006Date of Patent: August 17, 2010Assignee: Active Organics, LPInventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Publication number: 20090181047Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: ApplicationFiled: January 14, 2008Publication date: July 16, 2009Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Patent number: 7524504Abstract: Methods and compositions for reducing the levels of Advanced Glycation Endproducts (AGE) related proteins in the skin by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Ganoderma lucidum that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: GrantFiled: January 14, 2008Date of Patent: April 28, 2009Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Publication number: 20070160563Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: ApplicationFiled: January 11, 2006Publication date: July 12, 2007Inventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Patent number: 6656701Abstract: Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes which exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises at least one acidic buffering component that can reversibly disassociate hydrogen ions and has buffering capacity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient.Type: GrantFiled: January 29, 2002Date of Patent: December 2, 2003Assignee: Actim Organics, IncInventors: Michael Bishop, Glen Gillis, Scott J. Norton
-
Patent number: 6569437Abstract: Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically 5 acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes that exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises inorganic and/or organic acids or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient. The buffer is capable of reducing the pH of the surface of the skin to less than pH 5.5 and is susceptible to neutralization by normal epidermal processes.Type: GrantFiled: July 16, 1999Date of Patent: May 27, 2003Assignee: Active OrganicsInventors: Michael Bishop, Glen Gillis, Scott J. Norton
-
Publication number: 20020102285Abstract: Novel compositions comprising one or more of an acid protease and an acidic buffer, the acidic buffer comprising an acid and a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient, useful for treating or preventing abnormal biological conditions, diseases or disorders, and/or for improving the texture or appearance of the skin, and/or for enhancing epidermal exfoliation and/or for enhancing epidermal cell renewal and to methods for the use of the compositions. The acid protease comprises one or more proteolytic enzymes which exhibit proteolytic activity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. The acidic buffer comprises at least one acidic buffering component that can reversibly disassociate hydrogen ions and has buffering capacity at pH values below that of the surface of the skin, i.e., approximately pH 5.5. or mixtures thereof with a pharmaceutically or cosmetically acceptable carrier, vehicle or excipient.Type: ApplicationFiled: January 29, 2002Publication date: August 1, 2002Inventors: Michael Bishop, Glen Gillis, Scott J. Norton